McNeill Baur Revenue and Competitors

McNeill Baur PLLC, a nationally recognized biotech and pharma-focused IP boutique firm, provides comprehensive life science (biotech and pharma) patent prosecution and counseling services. McNeill Baur attorneys have significant prior US patent litigation experience, providing insight on creating and defending enforceable patents and understanding potential litigation risks. We are proud of our high-caliber clients and diverse and talented attorneys, agents, and staff and have a strong commitment to remote work-life balance. We are experts at the USPTO—our attorneys have an average of 15 years of experience, and our partners remain intimately involved in the day to day practice. We have more prosecution-focused attorneys with advanced degrees in life science or chemistry disciplines than many larger firms. Eleven of our professionals have PhD degrees, one of our professionals is a former USPTO examiner, and another was previously a clerk to the Honorable Kathleen O. Malley at the Federal Circuit. McNeill Baur’s patent practice spans the entire spectrum of pre-litigation patent practice. Our expertise includes patent prosecution, patent opinions, intellectual property portfolio management, due diligence investigations, patent appeals, USPTO proceedings. McNeill Baur attorneys have also handled many due diligence and freedom to operate projects for both investors and target companies. Since the firm was founded in 2014: • We have represented clients in more than 6,000 distinct prosecution, counseling, and USPTO post-grant proceeding matters. • We have prosecuted 671 active US applications in the USPTO • We have coordinated prosecution of over 1,600 non-US applications. Because our whole firm focuses on obtaining patents in the life science space, we can deliver the strongest protection for your valuable IP.